Monitoring is critical when using gentamicin in neonates. This includes measuring peak and trough serum levels, monitoring renal function through serum creatinine levels, and performing audiologic assessments to detect early signs of ototoxicity. Protocols for monitoring can vary, but typically involve checking serum levels after the third dose and periodically thereafter.
